Company Overview

Update
Founders:
Wei Li
Funding:
$25M
Categories:
Biotechnology
Description:
Innovent Biologics is a biopharmaceutical company developing and manufacturing monoclonal antibodies.

Detailed Description

Update

Innovent Biologics, Inc. is a privately held biopharmaceutical company that is dedicated to the development and manufacturing of monoclonal antibodies to be marketed in China and elsewhere around the world.

Innovent is funded by the venture arm of Fidelity, which is a major investment firm in the US, Lilly Ventures, and Suzhou bioBay. The registered capital is 30Million US Dollars. The founders and senior management team of Innovent have over 70 years of combined work experience in the discovery, development and manufacture of biologics in the US, Europe and worldwide and were involved in the launch of such products as Bexxar, Conbercept, Natrecor, Oncorine, Recombivax HB, and others.

Past Team (1)

Update
  • 80e34cd163a6a7e67d692c66cfe3d1c4

    Wei Li

    Founder and Founding Board Member
    Jun, 2011 - Jun, 2012

Funding Rounds (1) - $25M

Update

Investors (3)

Update
  • 3c4f14ae8d17a4f0daeebb53da0c0027

    Fidelity Growth Partners Asia

    Fidelity Growth Partners Asia (previously named Fidelity Asia Ventures) is the venture capital...
  • 15bc790960af00c78c84c3400efc8e6a

    Lilly Asia Ventures

    Lilly Asian Ventures makes venture capital investments in Asia for Eli Lilly and Company, a...
  • D3e1b3e814df8263aee6a5b51a21544d

    Fidelity Biosciences

    They are a division of Fidelity Investments, one of the world’s leading providers of financial...

Offices/Locations (2)

Update
  • Office

    Suzhou Industrial Park,

    CHN

  • Office

    Building C14, 218 Xinghu St.

    Suzhou Industrial Park

    , 215123

    China

Images (1)

Update
  • 3112b1bac47b2e2a717869939a978488